TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 45 filers reported holding TRINITY BIOTECH PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $106,000 | -0.9% | 28,100 | 0.0% | 0.00% | – |
Q4 2020 | $107,000 | +91.1% | 28,100 | 0.0% | 0.00% | – |
Q3 2020 | $56,000 | -8.2% | 28,100 | 0.0% | 0.00% | – |
Q2 2020 | $61,000 | +96.8% | 28,100 | 0.0% | 0.00% | – |
Q1 2020 | $31,000 | +6.9% | 28,100 | 0.0% | 0.00% | – |
Q4 2019 | $29,000 | -14.7% | 28,100 | 0.0% | 0.00% | – |
Q3 2019 | $34,000 | -34.6% | 28,100 | 0.0% | 0.00% | – |
Q2 2019 | $52,000 | -35.0% | 28,100 | 0.0% | 0.00% | – |
Q1 2019 | $80,000 | +25.0% | 28,100 | 0.0% | 0.00% | – |
Q4 2018 | $64,000 | -42.9% | 28,100 | 0.0% | 0.00% | – |
Q3 2018 | $112,000 | -20.6% | 28,100 | 0.0% | 0.00% | – |
Q2 2018 | $141,000 | -2.8% | 28,100 | 0.0% | 0.00% | – |
Q1 2018 | $145,000 | +0.7% | 28,100 | 0.0% | 0.00% | – |
Q4 2017 | $144,000 | -8.9% | 28,100 | 0.0% | 0.00% | – |
Q3 2017 | $158,000 | -6.5% | 28,100 | 0.0% | 0.00% | – |
Q2 2017 | $169,000 | +1.2% | 28,100 | 0.0% | 0.00% | – |
Q1 2017 | $167,000 | -17.7% | 28,100 | -4.4% | 0.00% | – |
Q4 2016 | $203,000 | -47.8% | 29,400 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $389,000 | +9.0% | 29,400 | -6.7% | 0.00% | 0.0% |
Q2 2016 | $357,000 | -5.8% | 31,500 | -3.1% | 0.00% | 0.0% |
Q1 2016 | $379,000 | -6.9% | 32,500 | -6.1% | 0.00% | 0.0% |
Q4 2015 | $407,000 | +2.8% | 34,600 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $396,000 | -38.8% | 34,600 | -3.4% | 0.00% | 0.0% |
Q2 2015 | $647,000 | -12.7% | 35,800 | -5.3% | 0.00% | 0.0% |
Q1 2015 | $741,000 | 0.0% | 37,800 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $741,000 | +7.2% | 37,800 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $691,000 | -17.5% | 37,800 | +3.8% | 0.00% | 0.0% |
Q2 2014 | $838,000 | -5.0% | 36,400 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $882,000 | -1.2% | 36,400 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $893,000 | -37.2% | 36,400 | -44.3% | 0.00% | -66.7% |
Q3 2013 | $1,423,000 | +196.5% | 65,400 | +129.5% | 0.00% | +200.0% |
Q2 2013 | $480,000 | – | 28,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |